IMHA Facts & figures

The Institute

  • The Institute of Musculoskeletal Health and Arthritis (IMHA) has six focus areas - Arthritis, Musculoskeletal (MSK) Rehabilitation, Bone, Skeletal Muscle, Skin and Oral Health.
  • IMHA's vision is to sustain health and enhance quality of life by eradicating the pain, suffering and disability caused by arthritis, musculoskeletal, oral and skin conditions.
  • Three strategic research priorities help guide the Institute's decision-making: Physical Activity, Mobility and Health; Tissue Injury, Repair and Replacement; Pain, Disability and Chronic Disease.

The facts

  • MSK diseases affect 11 million Canadians over the age of 12 years old annually (2010 report from the Canadian Orthopaedic Care Strategy Group).
  • The number of Canadians with MSK diseases is predicted to increase with the aging baby boomer population, from 11 million in 2007 to 15 million in 2031 (2010 report from the Canadian Orthopaedic Care Strategy Group).
  • According to a 2010 Public Health Agency of Canada report, more than 4.2 million Canadians aged 15 years or older self-reported being affected by arthritis in 2007-2008.
  • There are as many as 2 million Canadians suffering from osteoporosis (Osteoporosis Canada, 2010).
  • Psoriasis affects nearly 1 million Canadians (Canadian Skin Patient Alliance, 2010).
  • 12% of Canadians report experiencing ongoing pain in their mouth in the past year (Canadian Health Measures Survey, 2007-2009).

Economic impacts

  • In 2000, the economic burden of musculoskeletal diseases was the highest of any group of diseases, at $22.3 billion (Public Health Agency of Canada report).
  • In 2000, the economic burden of arthritis, resulting from both direct ($2.1 billion) and indirect ($4.3 billion) costs, was approximately $6.4 billion.
  • Treating osteoporosis and its resulting fractures costs approximately $1.9 billion each year in Canada (Osteoporosis Canada, 2010).
  • The economic burden of illness relating to skin is $1.47 billion in direct costs and $0.19 billion in indirect costs (Economic Burden of Illness in Canada, 1998).
  • In 2000, injury was the 5th most costly disease group, at $14.7 billion (2010 report from the Canadian Orthopaedic Care Strategy Group).

What IMHA is doing

  • Between 2000 and 2010, IMHA contributed more than $60 million to advance the science of MSK, oral and skin diseases and conditions.
  • As of 2011, fifteen CIHR Strategic Training Programs, seven of which are active, fall under the mandate of IMHA.
  • IMHA is a member of The Alliance for the Canadian Arthritis Program (ACAP) - comprised of ten individual Canadian stakeholder groups.
  • IMHA and its partners spearheaded the Osteoarthritis Consensus Conference in 2002 and the Frontiers in Inflammatory Joint Disease Consensus Conference in 2004. 
  • The Institute's Knowledge Exchange Task Force was formed in 2004.
  • In October 2005, the Canadian National Action Network of the Bone and Joint Decade, of which IMHA is a member, hosted the Annual Meeting of the International Bone and Joint Decade Committee.
  • In 2009, IMHA participated in the BJD Global Network Conference and Patient Advocacy Seminar in Washington, DC.
  • IMHA made Physical Activity, Mobility and Health (PAMH) its flagship strategic research priority for 2008-2013.